I learned that 136 million people—about one in three Americans—have diabetes or prediabetes. Many are unaware.

Shares of DexCom Inc. DXCM slumped 0.61% to $71.80 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 0.33% to 5,813.67 and ...

In addition, please check the fund’s top five holdings to know its best picks in 2024. Ithaka US Growth Strategy highlighted stocks like DexCom, Inc. (NASDAQ:DXCM), in the third quarter 2024 investor ...

In addition, please check the fund’s top five holdings to know its best picks in 2024. Baron Asset Fund highlighted stocks like DexCom, Inc. (NASDAQ:DXCM), in the third quarter 2024 investor letter.

Ithaka US Growth Strategy highlighted stocks like DexCom, Inc. (NASDAQ:DXCM), in the third quarter 2024 investor letter. DexCom, Inc. (NASDAQ:DXCM) is a medical device company that develops and ...

The consensus estimate for DexCom’s current full-year earnings is $1.69 per share. Leerink Partnrs also issued estimates for DexCom’s FY2027 earnings at $2.77 EPS and FY2028 earnings at $3.14 EPS.

Revenue growth and solid market position highlight DexCom's operational strengths. Investments in R&D and international expansion reflect strategic opportunities. Patent litigation and market ...

On Friday, TD Cowen maintained a positive outlook on DexCom (NASDAQ:DXCM) shares, with a reiterated Buy rating and a $100.00 price target. DexCom's third-quarter results slightly surpassed Wall Street ...

DexCom, Inc. DXCM reported better-than-expected third-quarter results on Thursday. DexCom reported quarterly earnings of 45 cents per share, which beat the analyst consensus estimate of 43 cents.

On Friday, TD Cowen maintained a positive outlook on DexCom (NASDAQ:DXCM) shares, with a reiterated Buy rating and a $100.00 price target. DexCom's third-quarter results slightly surpassed Wall ...

DexCom's stock has declined 35% since my last bearish article, validating my "Sell" rating, though past bearish calls were incorrect as the stock previously doubled and tripled. Q3 results showed ...